changing your setting. We'll assume that you are happy to receive all cookies on the BTG website.
London, UK, 08 July 2013
8 July 2013
On 23 May 2013, BTG plc (BTG or the Company), the specialist healthcare company, announced that it had entered into an agreement to buy EKOS Corporation (EKOS) conditional on Hart-Scott-Rodino (HSR) approval in the US.
BTG is pleased to announce that the applicable HSR waiting period has now expired and accordingly the acquisition completed on Friday, 5th July 2013.
Louise Makin – Chief Executive Officer +44 (0) 20 7575 0000
Rolf Soderstrom – Chief Financial Officer +44 (0) 20 7575 0000
Andy Burrows – Director of Investor Relations +44 (0) 20 7575 1741
FTI Consulting +44 (0)20 7831 3113
Select CONTINUE to proceed to the BTG website or LEAVE to learn more at BSC.com